-
-
Call more information
660-596-2224 -
Authors: Goodman CW and Brett AS. JAMA Intern Med 2019 Mar 25 Off-label use exposes patients to adverse effects and generally is not supported by evidence. The only conditions for which gabapentinoid drugs are FDA-approved to manage pain are postherpetic neuralgia (both gabapentin and pregabalin [Lyrica]) and diabetic neuropathy, spinal cord injury, and fibromyalgia (pregabalin only). […]
Read MoreAuthor: Michael Vlessides Anesthesiology News The use of intraoperative bispectral index (BIS) monitoring is effective in reducing time to extubation, time to spontaneous eye opening, PACU time and consumption of anesthetics, according to the results of a recent systemic review and meta-analysis. Nevertheless, the research team behind the study was quick to add that while […]
Read MoreAnesthesiology News An alarmingly high rate of patients with cancer have undiagnosed acute and chronic hepatitis. Investigators from SWOG Cancer Research Network, an international cancer clinical trials group funded by the National Cancer Institute, found that a substantial portion of newly diagnosed cancer patients with HBV or HCV were unaware of their viral infection. Many […]
Read MoreAuthors: Hsieh, S. Jean MD, MS et al Critical Care Medicine: July 2019 – Volume 47 – Issue 7 – p 885-893 Objectives: To measure the impact of staged implementation of full versus partial ABCDE bundle on mechanical ventilation duration, ICU and hospital lengths of stay, and cost. Design: Prospective cohort study. Setting: Two medical ICUs within Montefiore Healthcare Center (Bronx, NY). Patients: One […]
Read MoreAuthor: Michael Vlessides Anesthesiology News In patients with trismus, flexible fiber-optic intubation can be accomplished through the retromolar space, according to a new study. The researchers also noted an association between increasing body mass index (BMI) and decreasing size of the retromolar space. “Patients with head and neck cancers often present with trismus—they can’t open […]
Read More